HR3639-119

What This Bill Does

The VET PFAS Act expands VA health care and disability-benefit rules for PFAS exposure at military installations. Beginning 90 days after enactment, a veteran who served on active duty at a covered military installation where individuals were exposed to PFOA or other PFAS, including through contaminated drinking-water wells, becomes eligible for VA hospital care and medical services for listed diseases even when medical evidence is insufficient to prove attribution. For PFOA, the listed conditions include diagnosed high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension. For other PFAS, VA, consulting the Agency for Toxic Substances and Disease Registry, can include diseases with a positive association under the NDAA section 316 study. Specified reserve component service at exposed installations is treated as active duty for this purpose. The bill also creates section 1787A, making family members of covered veterans eligible for VA hospital care and medical services if they resided at the installation or were in utero while the mother resided there, for the same covered conditions, subject to advance appropriations, exclusion of conditions caused by something else under Under Secretary for Health guidelines, and exhaustion of reasonably available third-party payment claims. For three years after the NDAA PFAS study is submitted, VA must report annually to the House and Senate Veterans' Affairs Committees on the number of veterans and family members receiving care, conditions treated, denials and reasons, and pending eligibility decisions. A separate section creates a service-connection presumption for exposed veterans under chapter 11, treating covered diseases as incurred or aggravated in the line of duty and again including specified reserve service.

Who Benefits and How

Veterans exposed to PFAS at covered military installations benefit from VA care without having to prove definitive medical causation. Veterans with PFOA-linked conditions benefit because high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension are listed. Family members who lived on contaminated installations benefit from VA care eligibility for covered diseases. Children exposed in utero benefit because the family-member care rule includes prenatal residence exposure. Reserve component members benefit when specified service at covered installations is treated as active service.

Who Bears the Burden and How

VA health care administrators must determine covered installations, eligibility, care delivery, denials, and annual reporting. VA disability claims staff must apply the new PFAS service-connection presumption. Agency for Toxic Substances and Disease Registry staff must consult with VA on positive associations for other PFAS conditions. Family members and providers must exhaust reasonably available third-party payment claims before VA reimbursement. Federal taxpayers bear the cost of expanded care and compensation exposure subject to appropriations.

Key Provisions

• Expands VA care eligibility for veterans exposed to PFOA or other PFAS at covered military installations.
• Lists PFOA-linked conditions including high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension.
• Creates VA care eligibility for exposed family members and children exposed in utero.
• Requires third-party payment exhaustion and appropriations for family-member care.
• Creates a service-connection presumption for exposed veterans and treats specified reserve service as active service.
• Requires annual VA reports for three years on care, denials, pending claims, and covered conditions.